Bal Pharma Limited
BALPHARMA · NSE · ₹106 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Bal Pharma Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 34.5%; Net profit was ₹1.14 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹89 cr | +34.5% | Net profit: ₹1 cr | +445.7% | 1.3% | Company filing source |
| Mar 2026 | Revenue: ₹84 cr | +2.7% | Net profit: ₹4 cr | -33.0% | 4.3% | Company filing source |
| Dec 2025 | Revenue: ₹88 cr | — | Net profit: ₹2 cr | — | 2.0% | Company filing source |
| Sep 2025 | Revenue: ₹74 cr | — | Net profit: ₹1 cr | — | 1.0% | Company filing source |
| Jun 2025 | Revenue: ₹66 cr | -11.4% | Net profit: ₹0 cr | -19.7% | 0.3% | Company filing source |
| Mar 2025 | Revenue: ₹82 cr | — | Net profit: ₹5 cr | — | 6.6% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
SHAILESH SIROYA 17.2%Micro Labs Limited 12.6%ANITA SIROYA 6.6%Prakash Chandra Jain 3.4%Ram Keshav Murthy 3.3%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Bal Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.…
25 Sep 2026 · document
- Shareholders meeting. Bal Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the…
25 Sep 2026 · document
- Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
25 Sep 2026 · document
- Shareholders meeting. Bal Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026…
24 Sep 2026 · document
- Price movement. Significant movement in price has been observed in Bal Pharma Limited. The Exchange, in order to ensure that investors have latest relevant info…
10 Sep 2026 · document
- Price movement. Significant movement in price has been observed in Bal Pharma Limited. The Exchange, in order to ensure that investors have latest relevant info…
10 Sep 2026 · document
- General Updates. Bal Pharma Limited has informed the Exchange about Confirming the allotment of Convertible Warrants on Preferential basis…
07 Sep 2026 · document
- Record Date. Bal Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Sep-2026 and Communication to shareholders regardin…
27 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time